Here is something the veterinary acquisition market does not advertise openly: the sellers who would most prefer to sell to an independent buyer right now are also the ones most likely to accept a reasonable offer from one. That gap—between seller preference and market awareness—is where 2026 gets interesting.
Corporate veterinary medicine has spent the last decade rewriting how practices change hands. Private equity-backed consolidators moved fast, paid numbers individual buyers couldn’t touch, and treated independent acquisitions like a clearance event. In 2021, that description was essentially accurate. In 2026, it isn’t. Corporate buyers haven’t left — but they’ve gotten selective in ways that have opened a specific, findable segment of the market to individual buyers who understand what’s happening.
According to data published in Today’s Veterinary Business, corporations currently own roughly 30% of general practices in the U.S., account for approximately 50% of primary care revenue, and operate around 75% of specialty and emergency hospitals. That sounds like dominance—and in some markets it is. But 65% of general practices remain independently owned, and corporate appetite for that 65% has become far more measured than it was three years ago.
Why the Sellers Who Went Corporate Are Changing the Conversation:
This is the part of the M&A story that doesn’t get written about often enough, because the people who could tell it most honestly are usually still inside non-compete agreements.
The AAHA has documented that veterinarians employed in corporate settings report notably higher pressure to generate revenue and see more clients per shift compared to those in independent practices. Many sellers who signed during the 2021 peak are now two or three years into employment arrangements they underestimated at closing. Production targets that seemed reasonable in a conference room look different in year two. Clinical autonomy—the ability to decide how long an appointment runs, which specialist to refer to, how to handle a client who can’t afford care—has often eroded in ways the offer letter didn’t capture.
That experience is now influencing how practice owners think about their exits. Owners watching peers navigate post-sale corporate employment have updated their preferences. They want a buyer who will provide continuity of care without requiring three years of production targets as the price of retirement. That seller is not difficult to work with. That seller is motivated—and specifically open to an independent buyer.
What Corporate Selectivity Actually Left Behind:
The consolidation pace of 2020 and 2021 ran on conditions that no longer exist: near-zero interest rates and investor mandates to acquire volume above almost everything else. As rates rose and acquisition criteria tightened, corporate buyers shifted toward specifically targeting practices with $1 million or more in annual revenue, multiple-doctor operations, and real estate that can support service expansion. Single-doctor general practices, smaller suburban clinics, and rural operations that were fair game in 2021 are now largely off the corporate acquisition list.
That shift created an entire category of practice owners who passed on corporate offers during the peak years—either because the employment terms didn’t suit them or because the offer itself wasn’t what they hoped for—and now find themselves approaching retirement age with limited exit options and no corporate groups calling.
A veterinary practice acquisition in this segment typically looks like a single-doctor general practice generating $600,000 to $900,000 annually, owned by a veterinarian in their late 50s or early 60s who has been quietly thinking about an exit for two years. The practice is healthy. The staff is stable. And the buyer, if they show up prepared and pre-qualified, may be the only serious one in the room.
Texas: Where the Geographic Pattern Is Clearest
Geography shapes competitive pressure as much as practice size does, and Texas makes the contrast unusually visible. In Houston, Dallas, and Austin, vet business for sale activity draws interest from multiple buyer types simultaneously—corporate groups can acquire several practices within a 15-mile radius and build referral networks across them, which is exactly the clustering strategy that justifies their acquisition math. Independent buyers compete in those markets, but “competing” is the right word. It’s hard.
Drive two hours in almost any direction, and the picture changes. Lubbock, Tyler, Beaumont, the communities along the I-35 corridor between San Antonio and Laredo, the Hill Country markets—these are areas where corporate acquisition interest is genuinely limited because the geographic clustering strategy doesn’t work at that scale. The practices are often well-run, client bases are loyal and long-tenured, and sellers have no realistic corporate exit. An independent buyer with proper financing and a credible offer structure has leverage in these markets that doesn’t exist in a major metro. That leverage is real, and it’s currently underutilized.
This geographic pattern repeats across the country. Secondary markets in the Southeast, Midwest, and Mountain West states are all running a similar dynamic. The opportunity isn’t equally distributed—but it’s findable for buyers who know what they’re looking for.
The Timeline: How Long This Window Stays Open:
The conditions that make 2026 favorable for independent buyers reflect a specific phase of the consolidation cycle, not a permanent market shift. The Ackerman Group projects that one or two major veterinary consolidators are likely to go public in late 2026 or 2027. When that happens, public market capital will fuel another acquisition round, and criteria may broaden again. Practices currently accessible to individual buyers may not stay in that column.
If you are actively searching for veterinary clinics for sale—whether in Texas or another state—the combination of motivated sellers, reduced corporate competition in specific market segments, and accessible SBA financing creates a window that did not exist during the 2021 peak.
A buyer representative who understands where the market actually is right now — not where it was three years ago — makes a significant difference in identifying the right practice quickly rather than spending a year pursuing ones that won’t close.
Frequently Asked Questions:
Q1. How much are corporations paying for veterinary practices in 2026 — and has the number changed?
Corporate consolidators and private equity-backed groups are paying 10x to 16x adjusted EBITDA for qualifying veterinary practices in 2026, but the qualifying criteria have tightened considerably compared to the 2020 to 2022 peak acquisition period. During the consolidation peak, corporate buyers were acquiring practices across a wide range of sizes, geographies, and revenue profiles.
In 2026, the majority of corporate acquisition activity is concentrated on practices meeting a more specific profile: $1 million or more in annual revenue, two or more DVMs, real estate suitable for service expansion, and adjusted EBITDA above $400,000. Practices below those thresholds—which represent the majority of independently owned general practices in the U.S.—are receiving less corporate attention than at any point in the past five years.
According to data from the Ackerman Group, selling a veterinary practice to a corporation at the top multiples now requires practice characteristics that roughly 30% to 40% of independent practices meet. The practical implication for sellers is that the headline corporate multiple is real—but it applies to a narrower segment of the market than most owners assume when they hear it.
Sellers whose practices fall outside that profile are not failing to attract corporate interest; they’re operating in a segment where corporate veterinary medicine consolidators have made a deliberate strategic decision to reduce activity, which is precisely what creates the current opening for individual buyers.
Q2. What types of sellers are most open to independent buyers right now?
Owners approaching retirement who passed on corporate offers during the peak years, owners whose practice size no longer fits current corporate acquisition criteria, and sellers who have watched peers navigate post-sale corporate employment and decided they want a different exit. These sellers are motivated, realistic on price, and often actively looking for a buyer who will maintain continuity of care.
Q3. How to open your own veterinary practice?
To open your own veterinary practice, start with a strong business plan, a clear budget, and market research. Choose a location with demand, secure financing, register the business, and get the required veterinary licenses, permits, insurance, and compliance approvals.
Next, build out the clinic, buy equipment, hire veterinarians and support staff, set up practice management software, and create a local SEO and marketing plan before launch. AVMA recommends using a business plan and financial tools to prepare for long-term practice success.
Key steps:
Final Thoughts:
The vet business acquisition market in 2026 rewards preparation and market knowledge over capital size—which is a sentence that wasn’t true in 2021. Corporate consolidation hasn’t retreated; it’s refined. That refinement left a specific, findable segment of the market more accessible to individual buyers than it’s been in years. The sellers exist. The practices are sound. The competition, in the right markets, is manageable. The question worth sitting with is not whether the opportunity is real—it is—but whether you’ll be ready to move when the right practice surfaces.
Learn how VSC supports buyers navigating this market at vetsalesconsulting.com.
